Goldman Sachs Group Inc Genmab A/S Transaction History

Goldman Sachs Group Inc

  • $605 Billion
  • Q3 2024

A detailed history of Goldman Sachs Group Inc transactions in Genmab A/S stock. As of the latest transaction made, Goldman Sachs Group Inc holds 825,146 shares of GMAB stock, worth $17 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
825,146
Previous 877,852 6.0%
Holding current value
$17 Million
Previous $22.1 Million 8.81%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$23.84 - $28.48 $1.26 Million - $1.5 Million
-52,706 Reduced 6.0%
825,146 $20.1 Million
Q2 2024

Aug 13, 2024
BUY
$25.13 - $30.27 $5.59 Million - $6.74 Million
222,506 Added 33.95%
877,852 $22.1 Million
Q1 2024

May 15, 2024
BUY
$26.43 - $32.77 $3.37 Million - $4.18 Million
127,422 Added 24.14%
655,346 $19.6 Million
Q4 2023

Feb 13, 2024
SELL
$27.94 - $35.44 $3.03 Million - $3.84 Million
-108,410 Reduced 17.04%
527,924 $16.8 Million
Q3 2023

May 14, 2024
BUY
$35.27 - $42.24 $3.82 Million - $4.58 Million
108,410 Added 20.54%
636,334 $22.4 Million
Q3 2023

Nov 14, 2023
BUY
$35.27 - $42.24 $678,206 - $812,232
19,229 Added 3.12%
636,334 $22.4 Million
Q2 2023

May 14, 2024
SELL
$37.4 - $42.94 $7.18 Million - $8.25 Million
-192,064 Reduced 23.74%
617,105 $23.5 Million
Q2 2023

Aug 14, 2023
SELL
$37.4 - $42.94 $7.18 Million - $8.25 Million
-192,064 Reduced 23.74%
617,105 $23.5 Million
Q1 2023

May 14, 2024
BUY
$34.88 - $43.22 $2.92 Million - $3.61 Million
83,576 Added 11.52%
809,169 $30.6 Million
Q1 2023

May 11, 2023
BUY
$34.88 - $43.22 $2.92 Million - $3.61 Million
83,576 Added 11.52%
809,169 $30.6 Million
Q4 2022

May 14, 2024
SELL
$33.8 - $47.06 $462,248 - $643,592
-13,676 Reduced 1.85%
725,593 $30.8 Million
Q4 2022

Feb 13, 2023
SELL
$33.8 - $47.06 $462,248 - $643,592
-13,676 Reduced 1.85%
725,593 $30.8 Million
Q3 2022

May 14, 2024
BUY
$31.52 - $373.61 $7.2 Million - $85.4 Million
228,563 Added 44.75%
739,269 $23.8 Million
Q3 2022

Nov 10, 2022
BUY
$31.52 - $373.61 $7.2 Million - $85.4 Million
228,563 Added 44.75%
739,269 $23.8 Million
Q2 2022

May 14, 2024
SELL
$26.83 - $38.57 $461,958 - $664,098
-17,218 Reduced 3.26%
510,706 $16.6 Million
Q2 2022

Aug 15, 2022
SELL
$26.83 - $38.57 $12.2 Million - $17.5 Million
-454,462 Reduced 47.09%
510,706 $16.6 Million
Q1 2022

May 16, 2022
SELL
$30.95 - $39.68 $16.7 Million - $21.4 Million
-539,994 Reduced 35.88%
965,168 $34.9 Million
Q4 2021

Feb 14, 2022
SELL
$35.87 - $47.12 $4.33 Million - $5.69 Million
-120,831 Reduced 7.43%
1,505,162 $59.5 Million
Q3 2021

Nov 10, 2021
BUY
$41.55 - $48.72 $67.6 Million - $79.2 Million
1,625,993 New
1,625,993 $71.1 Million

Others Institutions Holding GMAB

# of Institutions
236
Shares Held
52.5M
Call Options Held
10.2K
Put Options Held
25.5K
View Full List

About GENMAB A/S

GMAB Quotes by TradingView
  • Ticker GMAB
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 658,292,992
  • Market Cap $13.6B
  • Description
  • Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphoc...
More about GMAB
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email